SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that it will host a key opinion leader (KOL) meeting on the topic of Nuclear Medicine and Diagnostics on June 15th in New York City.
About Dennis McDougallThis author has not yet filled in any details.
So far Dennis McDougall has created 58 blog entries.
SHINE and Rock Creek Innovations to Partner on Design and Implementation of Instrumentation and Control Protection Systems for Medical Isotope Plant
After breaking ground in August of 2017, JP Cullen completed the 6-month construction project three weeks ahead of schedule and on budget, with zero OSHA-recordable incidents. The 11,400 sq. ft. Building One will be one of the most advanced, private, nuclear technology facilities in the world.
Building One construction continues on schedule! Over 60 on-site work days with 0 accidents. Way to go JP Cullen! To view our other videos, visit our YouTube channel and hit subscribe to see the most recent and future updates.
U.S. Patent No. 9,734,926 relates to producing medical isotopes and expires December 23, 2032. This achievement demonstrates SHINE’s ongoing commitment to innovation and leadership in the medical isotope industry.
SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that it has chosen Baker Concrete Construction, Inc. (Baker) to be the prime contractor for the construction of its medical isotope production facility in Janesville, Wisconsin. In conjunction, Brad Wucherpfennig, President of Baker, has joined the SHINE board of directors.